Business- Page 71

Historic parliamentary vote reinforces Greenland’s growing strategic importance to U.S. and allied national securityCompany highlights Sarfartoq rare earths and Skaergaard precious metals as potential contributors to secure allied supply chains CHARLOTTE, N.C.,

New product identifies threats, verifies them, and protects against them with AI-driven triage, 24/7 human analysts, built-in offensive analysis, and unlimited incident response MCLEAN, Va., Nov. 04, 2026 (GLOBE NEWSWIRE) — Cycurion,

Part of a broader series of DaaS contract opportunities currently under negotiation; Company targets profit margins of 40%–60% through drone integration and proprietary AI data analytic software processing VANCOUVER, British Columbia, Nov.

Google credit support strengthens TeraWulf’s ability to secure competitive project financing for contracted AI infrastructure at Hawesville, Kentucky campus Fluor agreement expands engineering and construction capacity, with defined delivery milestones EASTON, Md.,

–     Oral tablet formulation of elraglusib as a monotherapy significantly inhibited tumor growth and       enhanced antitumor immune activity in an aggressive, poorly immunogenic melanoma model –     Phase

Webinar will be held on November 5, 2026, at 11:00 AM Eastern Time NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) — Our Bond, Inc. (“Bond”) (NASDAQ: OBAI), the creator of the world’s

Late-breaking presentation will report long-term durability preclinical data for STX-1150, Scribe’s lead epigenetic silencing therapy for LDL cholesterol reduction now in clinical trials A second presentation will reveal enhanced potency and specificity

Proposed Acquisition Strategically Expands Eagle’s Domestic Uranium Resource Portfolio RENO, Nev., Nov. 04, 2026 (GLOBE NEWSWIRE) — Eagle Nuclear Energy Corp. (“Eagle” or the “Company”) (NASDAQ: NUCL), a next-generation nuclear energy company,

WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the Quarter; Reiterates Full Year Guidance of $1.0B to $1.04B Repeated Once-Daily Dosing

MALVERN, Pa., Nov. 04, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care